Macrogenics Inc (MGNX)
15.61
-0.47
(-2.92%)
USD |
NASDAQ |
Apr 19, 16:00
15.61
0.00 (0.00%)
After-Hours: 20:00
Macrogenics Enterprise Value: 774.10M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 18, 2024 | 774.10M |
April 17, 2024 | 775.35M |
April 16, 2024 | 811.56M |
April 15, 2024 | 827.79M |
April 12, 2024 | 865.25M |
April 11, 2024 | 925.81M |
April 10, 2024 | 909.58M |
April 09, 2024 | 900.21M |
April 08, 2024 | 915.82M |
April 05, 2024 | 908.95M |
April 04, 2024 | 880.24M |
April 03, 2024 | 623.64M |
April 02, 2024 | 601.16M |
April 01, 2024 | 645.49M |
March 28, 2024 | 689.19M |
March 27, 2024 | 704.18M |
March 26, 2024 | 657.98M |
March 25, 2024 | 669.84M |
March 22, 2024 | 674.21M |
March 21, 2024 | 731.02M |
March 20, 2024 | 731.02M |
March 19, 2024 | 742.89M |
March 18, 2024 | 744.13M |
March 15, 2024 | 764.74M |
March 14, 2024 | 772.85M |
Date | Value |
---|---|
March 13, 2024 | 804.07M |
March 12, 2024 | 869.00M |
March 11, 2024 | 827.79M |
March 08, 2024 | 858.38M |
March 07, 2024 | 1.051B |
March 06, 2024 | 1.111B |
March 05, 2024 | 1.059B |
March 04, 2024 | 1.064B |
March 01, 2024 | 960.15M |
February 29, 2024 | 883.74M |
February 28, 2024 | 837.19M |
February 27, 2024 | 841.53M |
February 26, 2024 | 813.60M |
February 23, 2024 | 896.16M |
February 22, 2024 | 832.22M |
February 21, 2024 | 827.88M |
February 20, 2024 | 835.95M |
February 16, 2024 | 842.78M |
February 15, 2024 | 850.22M |
February 14, 2024 | 833.46M |
February 13, 2024 | 847.12M |
February 12, 2024 | 882.50M |
February 09, 2024 | 845.26M |
February 08, 2024 | 906.09M |
February 07, 2024 | 852.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.99M
Minimum
Jun 16 2022
1.796B
Maximum
Apr 29 2021
557.51M
Average
384.50M
Median
Enterprise Value Benchmarks
Allurion Technologies Inc | 98.22M |
United Therapeutics Corp | 8.861B |
MEI Pharma Inc | -37.83M |
Marinus Pharmaceuticals Inc | 0.1387M |
Voyager Therapeutics Inc | 179.09M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -46.07M |
Revenue (Quarterly) | 9.164M |
Total Expenses (Quarterly) | 58.52M |
EPS Diluted (Quarterly) | -0.75 |
Gross Profit Margin (Quarterly) | 98.22% |
Profit Margin (Quarterly) | -502.7% |
Earnings Yield | -1.02% |
Normalized Earnings Yield | -13.29 |